634 related articles for article (PubMed ID: 22228044)
1. Evaluation of MBEC™-HTP biofilm model for studies of implant associated infections.
Coraça-Hubér DC; Fille M; Hausdorfer J; Pfaller K; Nogler M
J Orthop Res; 2012 Jul; 30(7):1176-80. PubMed ID: 22228044
[TBL] [Abstract][Full Text] [Related]
2. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections.
Saginur R; Stdenis M; Ferris W; Aaron SD; Chan F; Lee C; Ramotar K
Antimicrob Agents Chemother; 2006 Jan; 50(1):55-61. PubMed ID: 16377667
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the in vitro activities of ceftobiprole and comparators in staphylococcal colony or microtitre plate biofilm assays.
Abbanat D; Shang W; Amsler K; Santoro C; Baum E; Crespo-Carbone S; Lynch AS
Int J Antimicrob Agents; 2014 Jan; 43(1):32-9. PubMed ID: 24252780
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility to antibiotics of staphylococci in biofilms isolated from orthopaedic infections.
Molina-Manso D; del Prado G; Ortiz-Pérez A; Manrubia-Cobo M; Gómez-Barrena E; Cordero-Ampuero J; Esteban J
Int J Antimicrob Agents; 2013 Jun; 41(6):521-3. PubMed ID: 23611308
[TBL] [Abstract][Full Text] [Related]
5. Low-energy shock waves enhance the susceptibility of staphylococcal biofilms to antimicrobial agents in vitro.
Wanner S; Gstöttner M; Meirer R; Hausdorfer J; Fille M; Stöckl B
J Bone Joint Surg Br; 2011 Jun; 93(6):824-7. PubMed ID: 21586784
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial coating agents: can biofilm formation on a breast implant be prevented?
van Heerden J; Turner M; Hoffmann D; Moolman J
J Plast Reconstr Aesthet Surg; 2009 May; 62(5):610-7. PubMed ID: 18359675
[TBL] [Abstract][Full Text] [Related]
7. Staphylococcus aureus biofilm formation and antibiotic susceptibility tests on polystyrene and metal surfaces.
Coraça-Huber DC; Fille M; Hausdorfer J; Pfaller K; Nogler M
J Appl Microbiol; 2012 Jun; 112(6):1235-43. PubMed ID: 22435667
[TBL] [Abstract][Full Text] [Related]
8. Tolerant Small-colony Variants Form Prior to Resistance Within a Staphylococcus aureus Biofilm Based on Antibiotic Selective Pressure.
Manasherob R; Mooney JA; Lowenberg DW; Bollyky PL; Amanatullah DF
Clin Orthop Relat Res; 2021 Jul; 479(7):1471-1481. PubMed ID: 33835090
[TBL] [Abstract][Full Text] [Related]
9. Biofilm-forming capacity of Staphylococcus epidermidis, Staphylococcus aureus, and Pseudomonas aeruginosa from ocular infections.
Hou W; Sun X; Wang Z; Zhang Y
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5624-31. PubMed ID: 22736609
[TBL] [Abstract][Full Text] [Related]
10. High in vitro antimicrobial activity of synthetic antimicrobial peptidomimetics against staphylococcal biofilms.
Flemming K; Klingenberg C; Cavanagh JP; Sletteng M; Stensen W; Svendsen JS; Flaegstad T
J Antimicrob Chemother; 2009 Jan; 63(1):136-45. PubMed ID: 19010828
[TBL] [Abstract][Full Text] [Related]
11. Rifampicin-containing combinations are superior to combinations of vancomycin, linezolid and daptomycin against Staphylococcus aureus biofilm infection in vivo and in vitro.
Jørgensen NP; Skovdal SM; Meyer RL; Dagnæs-Hansen F; Fuursted K; Petersen E
Pathog Dis; 2016 Jun; 74(4):ftw019. PubMed ID: 27036412
[TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci.
Lee JY; Ko KS; Peck KR; Oh WS; Song JH
J Antimicrob Chemother; 2006 Jun; 57(6):1110-5. PubMed ID: 16556639
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of antimicrobial effects of novel implant materials by testing the prevention of biofilm formation using a simple small scale medium-throughput growth inhibition assay.
Patenge N; Arndt K; Eggert T; Zietz C; Kreikemeyer B; Bader R; Nebe B; Stranak V; Hippler R; Podbielski A
Biofouling; 2012; 28(3):267-77. PubMed ID: 22435853
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility of Staphylococcus aureus and Staphylococcus epidermidis biofilms isolated from infected total hip arthroplasty cases.
Nishimura S; Tsurumoto T; Yonekura A; Adachi K; Shindo H
J Orthop Sci; 2006 Jan; 11(1):46-50. PubMed ID: 16437348
[TBL] [Abstract][Full Text] [Related]
15. In vitro efficacy of antimicrobial agents against high-inoculum or biofilm-embedded meticillin-resistant Staphylococcus aureus with vancomycin minimal inhibitory concentrations equal to 2 μg/mL (VA2-MRSA).
Tang HJ; Chen CC; Ko WC; Yu WL; Chiang SR; Chuang YC
Int J Antimicrob Agents; 2011 Jul; 38(1):46-51. PubMed ID: 21549575
[TBL] [Abstract][Full Text] [Related]
16. Effects of vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms.
Hajdu S; Lassnigg A; Graninger W; Hirschl AM; Presterl E
J Orthop Res; 2009 Oct; 27(10):1361-5. PubMed ID: 19396814
[TBL] [Abstract][Full Text] [Related]
17. Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin.
Smith K; Perez A; Ramage G; Gemmell CG; Lang S
Int J Antimicrob Agents; 2009 Apr; 33(4):374-8. PubMed ID: 19101124
[TBL] [Abstract][Full Text] [Related]
18. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
Rose WE; Poppens PT
J Antimicrob Chemother; 2009 Mar; 63(3):485-8. PubMed ID: 19109338
[TBL] [Abstract][Full Text] [Related]
19. Effect of sub-lethal doses of vancomycin and oxacillin on biofilm formation by vancomycin intermediate resistant Staphylococcus aureus.
Mirani ZA; Jamil N
J Basic Microbiol; 2011 Apr; 51(2):191-5. PubMed ID: 20967790
[TBL] [Abstract][Full Text] [Related]
20. Telavancin: in vitro activity against staphylococci in a biofilm model.
Gander S; Kinnaird A; Finch R
J Antimicrob Chemother; 2005 Aug; 56(2):337-43. PubMed ID: 15972312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
